Fabien S.
- Country
- France
- Department
- Service Urologie et Transplatation
Research Overview
Data & Insights
Has run more than one trial at 0 of 55 partner sites.
Specializations
Urologic Oncology
The investigator specializes in treating non-muscle invasive bladder cancer, focusing on innovative therapeutic approaches that combine immunotherapy with conventional treatments.
- Bladder Cancer Management
- Immunotherapy Integration
- Intravesical Therapy
Primary research interests include developing enhanced treatment protocols for early-stage bladder cancer using combination therapies.
Immunotherapy Research
Expertise in studying immune checkpoint inhibitors and their application in urological cancers, with particular attention to combination approaches with established treatments.
- Checkpoint Inhibitor Therapy
- Combination Treatment Strategies
- Treatment Response Assessment
The investigator explores innovative therapeutic combinations to enhance treatment outcomes in early-stage cancer.
Clinical Outcomes
Focus on evaluating disease-free survival and treatment efficacy in bladder cancer patients, particularly in the context of combination therapeutic approaches.
- Treatment Efficacy Analysis
- Safety Profile Assessment
- Long-term Outcome Studies
Specialized in monitoring and analyzing therapeutic responses in early-stage bladder cancer treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.